A shocking revelation has come to light, exposing a critical failure by Health Canada to heed expert advice on expanding access to safe drugs for opioid users. This oversight has potentially dire consequences for those struggling with addiction.
In Vancouver, TJ Felix, a resilient individual with a history of drug exposure since childhood, shares a harrowing story. Felix's journey to stability began with a compassion club providing a safe supply of heroin, a lifeline that was abruptly cut off in 2023.
"I would rather die than go through intense withdrawal again," Felix confesses. Their life, once consumed by the fear of sickness, now hangs in the balance.
Internal documents obtained by the fifth estate reveal a disturbing trend. Despite expert recommendations to expand access to a range of safe, regulated drugs, the federal government's support for safe supply programs waned and eventually ceased in March.
But here's where it gets controversial...
The origins of safe supply can be traced back to 2016, when physicians across Canada, from Vancouver to London, Ont., began prescribing hydromorphone tablets to opioid users. The goal was clear: keep people alive by offering a predictable, pharmaceutical alternative to the deadly street supply laced with fentanyl.
However, the program fell short for many, including Felix, who found the prescribed amounts insufficient.
Enter the Drug User Liberation Front (DULF), a compassion club with a bold mission: to provide a legal, regulated supply of drugs to users. DULF's operation, supported by local authorities, tested and labeled drugs to ensure safety. But their efforts were met with resistance.
In 2022, Health Canada denied DULF an exemption to the Controlled Drug and Substances Act, and the founders were arrested and charged. Despite positive outcomes for club members, including Felix, the government's stance remained unwavering.
And this is the part most people miss...
Jordan Westfall, a co-chair of Health Canada's expert committee on safe supply, feels the government ignored evidence-based solutions. Westfall and his colleagues warned that hydromorphone tablets might not match the potency of street drugs laced with fentanyl.
"It's heartbreaking," Westfall says. "We had evidence, and it was ignored."
Despite recommendations to expand safe supply to include a greater range of drugs, including stimulants and injectable opioids, Health Canada's funding for prescribed safe supply programs ended in March.
People like Felix are caught in the crossfire of a political debate, left with no choice but to rely on deadly street drugs to manage withdrawal symptoms.
"We need grace," Felix pleads. "Without a safe supply, there's no hope for recovery."
The question remains: will the federal government reconsider its stance on safe supply, or will more lives be lost in the war on drugs?
